Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Meta and Apple team up to make Muse AI models run better on Macs

October 15, 2026

Calgary Stampeders need help to reach CFL playoffs

October 15, 2026

Flintstones vitamins, Aleve and Claritin tablets hit in new recall

October 15, 2026

Sony made a $5,900 gold-plated Walkman MP3 player

October 15, 2026

Fisheries sector fund gets $300 million extension from Ottawa, Atlantic provinces

October 15, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Europe MRD Testing Market Report 2024: Analysis and Forecasts 2023-2033 Featuring Cergentis , F. Hoffmann-La Roche, and ICON
Press Release

Europe MRD Testing Market Report 2024: Analysis and Forecasts 2023-2033 Featuring Cergentis , F. Hoffmann-La Roche, and ICON

By News RoomFebruary 6, 20243 Mins Read
Europe MRD Testing Market Report 2024: Analysis and Forecasts 2023-2033 Featuring Cergentis , F. Hoffmann-La Roche, and ICON
Share
Facebook Twitter LinkedIn Pinterest Email

Dublin, Feb. 06, 2024 (GLOBE NEWSWIRE) — The “Europe MRD Testing Market: Analysis and Forecast, 2023-2033” report has been added to ResearchAndMarkets.com’s offering.

The Europe MRD testing market is projected to reach $1.74 billion by 2033 from $0.42 billion in 2023, growing at a CAGR of 15.19%

The MRD testing market is experiencing growth due to various factors, such as the extension of medicare coverage for MRD testing and its utilization in diagnosing solid tumors. With the rise in consumer awareness, there is a growing demand for MRD testing in recent times. Healthcare professionals and researchers are acknowledging this shift and working towards incorporating MRD testing into clinical procedures to meet patient demands.

The MRD testing market in Europe is witnessing significant growth, driven by the adoption of advanced techniques like polymerase chain reaction (PCR), next-generation sequencing (NGS), and flow cytometry. This approach plays a pivotal role in the detection and quantification of residual cancer cells post-treatment.

MRD testing holds clinical importance in Europe as it enables healthcare providers to closely monitor treatment response, assess the risk of relapse, tailor personalized therapeutic strategies, and serves as a crucial endpoint in clinical trials. This proactive approach to identifying and addressing minimal residual disease empowers healthcare professionals to aim for improved treatment outcomes and enhanced patient survival rates across the European healthcare landscape. The growing recognition of MRD testing’s significance is expected to drive continued expansion in this market throughout the region.

How can this report add value to an organization?

Growth/Marketing Strategy: The Europe MRD testing market has seen major development by key players operating in the market, such as business expansion, partnership, collaboration, and joint venture. The favored strategy for the companies has been partnerships and collaborations to strengthen their position in the MRD testing market.

Competitive Strategy: Key players in the Europe MRD testing market analyzed and profiled in the study involve major residual testing-based companies and test manufacturers. Moreover, a detailed competitive benchmarking of the players operating in the Europe MRD testing market has been done to help the reader understand how players stack against each other, presenting a clear market landscape.

Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Attributes:

Report Attribute Details
No. of Pages 66
Forecast Period 2023 – 2033
Estimated Market Value (USD) in 2023 $0.42 Billion
Forecasted Market Value (USD) by 2033 $1.74 Billion
Compound Annual Growth Rate 15.1%
Regions Covered Europe

Key Topics Covered:

Executive Summary

1 Markets
1.1 Market Scope
1.1.1 Key Questions Answered in the Report
1.2 Research Methodology
1.2.1 MRD Testing Market: Research Methodology
1.2.2 Data Sources
1.3 Market Estimation Model
1.3.1 Criteria for Company Profiling

2 Market Overview
2.1 MRD Testing Workflow Analysis
2.2 MRD Testing: Solid Tumor vs. Hematological Malignancy
2.3 Evolution of MRD Testing
2.4 Market Footprint
2.5 Market Size and Future Growth Potential

3 Industry Insights
3.1 Legal and Regulatory Framework of MRD Tests
3.1.1 Europe
3.1.2 European Union
3.2 Supply Chain Analysis
3.2.1 For Laboratory Developed Tests (LDTs)
3.2.2 For In-Vitro Diagnostics (IVDs)

4 Minimal Residual Disease Testing Market (by Region), 2022-2033
4.1 Overview
4.2 Europe
4.2.1 Europe MRD Testing Market, by End User
4.2.2 Europe MRD Testing Market, by Country

5 Company Profiles
5.1 Overview
5.2 MRD Testing Ecosystem Active Players
5.3 Cergentis B.V.
5.3.1 Company Overview
5.3.2 Role of Cergentis B.V. in the MRD Testing Market
5.3.3 Analyst Perspective
5.4 F. Hoffmann-La Roche Ltd
5.5 ICON plc

For more information about this report visit https://www.researchandmarkets.com/r/6dv6mr

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

  • European MRD Testing Market

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

vineyard vines Returns as Official Style of the Head Of The Charles® Regatta

Bigger & Better Than Ever: Laxmi & Chef Kunal Kapur Return With ‘Diwali Delights’ Season 2

2026 Chery International User Summit to Kick Off: LUXEED Set for Global Brand Launch

Going Asset Management Wins Capital’s Excellence Fund Award, Harnessing Technology to Enhance the Long-Term Value of Assets

Alation Honors 2026 AI Radicals Award Winners at revAlation

Supported Employment: Helping Individuals Build Meaningful Careers

“The Carbon Pursuit of Happiness” Premieres October 10: A New Chapter for In-Depth Dialogue on Health and Humanity

Evolution Metals & Technologies Corp. Raises Fiscal 2026 Revenue Guidance 62% at Midpoint to 11 Million and Reaffirms 460 Million Fiscal 2027 Outlook

Ufunded Launches “Spotlight” Series, Documenting the Minds Shaping Modern Trading

Editors Picks

Calgary Stampeders need help to reach CFL playoffs

October 15, 2026

Flintstones vitamins, Aleve and Claritin tablets hit in new recall

October 15, 2026

Sony made a $5,900 gold-plated Walkman MP3 player

October 15, 2026

Fisheries sector fund gets $300 million extension from Ottawa, Atlantic provinces

October 15, 2026

Latest News

Friends don’t let friends feed their data to AI agents

October 15, 2026

As bond yields rise, how to pick between a variable or fixed rate mortgage?

October 15, 2026

Carney says he expects nations, including U.S., to stay out of Alberta vote

October 15, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version